Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Addeasy Biotechnology (Weifang Addeasy Bio-Technology Co., Ltd.) is a Chinese high-tech animal nutrition and biotechnology company founded in 2004. The company specializes in the research, development, manufacture, and sale of feed additives, organic acid preparations, probiotics, and plant extracts for livestock, poultry, and aquaculture. Its product portfolio includes feed acidifiers, mold inhibitors, antioxidants, mycotoxin binders, and gut health promoters such as tributyrin and probiotics. Addeasy operates a large-scale production facility in Weifang, Shandong, and exports its products globally to regions including Southeast Asia, Europe, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Add Easy.